FDA Approved: AFREZZA — Supplemental Application (Mannkind Corporation)

View source ↗

Summary

FDA approved a supplemental application for AFREZZA (insulin human) submitted by Mannkind Corporation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus

Drugs mentioned

• Afrezza (Technosphere insulin)

Snippet

SUPPL AP for AFREZZA (INSULIN HUMAN)